News May 23, 2011
How does one control and modify the self-assembly process of organic molecules towards a desired solid state? Andreas Lemmerer, Joel Bernstein and Volker Kahlenberg ask themselves this very question in their recent CrystEngComm Hot Article.
Isoniazid is an active pharmaceutical ingredient that helped cure tuberculosis as part of a triple therapy cocktail. It co-crystallizes with carboxylic acids to form pharmaceutical co-crystals and is also a versatile supramolecular reagent as it has multiple donor and accepting groups to interact with different functional groups. Find out more about this study and Isoniazid in the article – FREE to read until 31 May 2011.
Reproduced by permission from The Royal Society of Chemistry from CrystEngComm Blog at http://blogs.rsc.org/ce/
Multidisciplinary Study Suggests New Strategy for Drug DiscoveryNews
A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results, , suggest a new strategy for drug discovery.READ MORE
Marburg Virus: Workings of the First Promising Treatment RevealedNews
Scientists have discovered the workings of the first promising treatment for Marburg virus, a pathogen with the same pandemic potential as Ebola virus. The research builds on previous studies showing that an antibody called MR191 can neutralize Marburg—though no one knew exactly how it targeted the virus.READ MORE